Hympavzi Interactions
There are 10 drugs known to interact with Hympavzi (marstacimab), along with 2 disease interactions. Of the total drug interactions, 1 is major, and 9 are moderate.
- View Hympavzi disease interactions (2)
Medications known to interact with Hympavzi
Note: Showing generic names only.
Hympavzi disease interactions
There are 2 disease interactions with Hympavzi (marstacimab) which include:
Report options
More about Hympavzi (marstacimab)
- Hympavzi consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Lysteda
Lysteda (tranexamic acid) is used to treat heavy menstrual bleeding. Includes Lysteda side effects ...
DDAVP
DDAVP is used for diabetes insipidus, hemophilia a, primary nocturnal enuresis, von Willebrand Disease
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Qfitlia
Qfitlia is used for hemophilia a, hemophilia a with inhibitors, hemophilia b, hemophilia b with ...
Altuviiio
Altuviiio is a once-weekly recombinant fact VIII replacement therapy used by hemophilia A patients ...
Cyklokapron
Cyklokapron is used for bleeding disorder, factor ix deficiency, hemophilia a
Hemlibra
Hemlibra is a monoclonal antibody that functions in place of a natural blood-clotting factor that ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.